12 months

Business development

Revenue

1 007​

2 928​

5 628

5 127

7 895

Personnel on average

39​

70​

81

42

36

Personnel at the end of the period

39​

23​

82

80

37

Research and development costs

35 315​

12 229​

21 109

8 730

9 053

Capital expenditure

65​

270​

475

116

287 

Profitability

Operating profit (loss)

-41 510​

-20 720​

-17 631

-5 121

-1 769

 as percentage of revenue, %

-4 122.14​

-707.65​

-313.27

-99.90

-22.4

Profit (loss) before taxes

-39 482​

-21 573​

-17 942

-5 553

-1 726

 as percentage of revenue, %

-3 920.75​

-736.78​

-318.80

-108.30

-21.9

Balance sheet

Liquid assets

33 938​

4 059​

19 744

25 238

28 243

Shareholders´ equity

73 337​

-29 466​

-8 938

110

-11 117

Balance sheet total

118 236​

11 205​

31 526

42 804

30 075

Financial ratios

Return on equity, %

-​

-​

-

-

-

Return on capital employed, %

-82.8​

-341.5​

-86.0

-18.3

-7.2

Equity ratio, %

62.0​

-263.0​

-28.4

0.3

-37.0

Gearing, %

-67.9

-148.5

40.8

Per share data

Earning per share (EPS,) €

-0.09​

-0.15​

-0.11

-0.06

-0.02

Shareholders´ equity per share, €

-0.19​

-0.17​

-0.06

0.0008

-0.12

Dividend per share, €

-

-

-

Payout ratio, %

-

-

-

Effecting dividend yield, %

-

-

-

P/E ratio

-

-

-

Share price, €

- Lowest share price

0.34​

0.30​

0.23

0.24

0.75

- Highest share price

0.65​

0.67

0.94

1.22

- Average share price

0.48​

0.42

0.51

0.98

- 31.12. share price

0.50​

0.50​

0.55

0.26

0.76

Market capitalization, Meur

193.8​

88.0​

87.3

37.5

68.6

Trade of shares

Number of shares traded

243 335 806​

90 049 678​

51 471 584

15 350 613

35 093 743

  as percentage of all shares, %

62.8​

51.2​

32.4

10.6

38.9

Adjusted weighted average number
of shares during the period

365 219 028​

161 919 250​

144 992 735

96 734 553

90 003 192

Adjusted weighted number
of shares at the end of the period

387 594 457​

176 003 931​

158 752 560

144 320 560

90 211 860

Adjusted weighted average number
of shares during the period, fully diluted

368 000 705​

164 309 750​

147 677 878

97 562 553

91 697 875

Adjusted weighted number
of shares at the end of the period, fully diluted

390 376 134​

178 394 431​

161 437 703

145 148 560

91 906 543